Your session is about to expire
← Back to Search
Ultrasound Therapy
Study device treatment for Rheumatoid Arthritis
N/A
Waitlist Available
Led By Erik Peterson, MD PHD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Males and Females aged 18 and over.
Must carry a diagnosis of rheumatoid arthritis, as defined by the American College of Rheumatology in 2010: (https://www.rheumatology.org/Portals/0/Files/2010_revised_criteria_classification_ra.pdf).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0 (baseline) to day 14 (end of treatment)
Awards & highlights
Study Summary
Ultrasound Treatment of Rheumatoid Arthritis
Eligible Conditions
- Rheumatoid Arthritis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 0 (baseline) to day 14 (end of treatment)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0 (baseline) to day 14 (end of treatment)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Within-arm change in the Disease Activity Score (DAS-28) from baseline to end of treatment for treatment group.
Secondary outcome measures
Between-arm change in the DAS-28 from baseline to end of treatment.
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Study device treatmentExperimental Treatment1 Intervention
Transcutaneous non-invasive ultrasound will be administered to the spleen for 30 minutes every day for 2 weeks (14 days total) via a portable device.
Group II: Sham device treatmentPlacebo Group1 Intervention
Sham treatment will be administered to the spleen for 30 minutes every day for 2 weeks (14 days total) via a portable device.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Study device treatment
2018
N/A
~20
Find a Location
Who is running the clinical trial?
University of MinnesotaLead Sponsor
1,368 Previous Clinical Trials
1,587,505 Total Patients Enrolled
2 Trials studying Rheumatoid Arthritis
1,762 Patients Enrolled for Rheumatoid Arthritis
Erik Peterson, MD PHDPrincipal InvestigatorUniversity of Minnesota
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger